D
iseases of the small intestine, termed enteropathies, are a common cause of diarrhea. 1 The small intestine functions as both an absorptive and a secretory organ. When damaged, both absorptive failure and secretion excess can occur. 1 Features of clinically significant enteropathy include diarrhea and malabsorption, leading to weight loss. Oily, pale, foul-smelling, or bulky stools; postprandial bowel movements; and bloating are suggestive of steatorrhea. 1 Enteropathies are of particular interest to internists and gastroenterologists alike because the differential diagnosis is challenging and extensive. Thus, a thorough systemic evaluation is required to identify both the cause and direct therapy.
Numerous patients present with diarrhea, but not all have an enteropathy. We must identify the more serious cases because of the potentially significant effect on morbidity and mortality. The malabsorption associated with enteropathies can be severe, and at times it can require parenteral nutrition. In certain cases, namely, collagenous sprue and Whipple disease, enteropathy can be fatal. It is important to determine the cause of enteropathy because although certain principles of management, such as corticosteroids, are similar in different etiologies, there are also unique therapeutic options that depend on the underlying diagnosis.
Although there are myriad causes of enteropathy, we will limit the scope of this article to those that cause villous atrophy, thereby creating an environment of malabsorption resulting in clinically significant weight loss and possible nutritional deficiencies in addition to diarrhea. We will focus on the high-yield etiologies that are the most common (celiac disease [CD] , medications, collagenous sprue, and common variable immune deficiency) and on the not to miss diagnoses (human immunodeficiency virus [HIV] , tropical sprue, giardiasis, Whipple disease, and viral infection). As such, this article will not address small-bowel ischemia, food allergies, Crohn disease, abetalipoproteinemia, amyloidosis, eosinophilic enteritis, tuberculosis, Zollinger-Ellison syndrome, gastric metaplasia, lymphoproliferative diseases, autoimmune enteropathy, small intestinal bacterial overgrowth, and others. 2 Items from this list will be briefly highlighted in our comprehensive table (Table) , but not discussed. Relative frequencies of causes of villous atrophy not including CD are shown in Figure 1 .
COMMON CAUSES OF VILLOUS ATROPHY
We begin by addressing some of the most common causes of enteropathy.
Celiac Disease Including Seronegative
Celiac disease (CD) is an autoimmune disorder involving chronic inflammation of the small intestine due to an immune reaction against ingested gluten. Seropositive and seronegative CD are the most common causes of enteropathy causing villous atrophy. Celiac disease affects roughly 1% of the population and is largely undiagnosed. 1 The broad range of presentations may partially explain this deficit in diagnosis. Although classical CD presents with malabsorption, it can also present with atypical symptoms, such as elevated liver enzymes and infertility, or with no symptoms. These nonclassical presentations are increasing in frequency, particularly in the undiagnosed cohort.
Current guidelines recommend case finding for detection of CD, which involves testing individuals with either classical or nonclassical symptoms, or associated at-risk conditions such as autoimmune diseases or Down syndrome. 6 A family history of CD is a significant risk factor and should be sought in the history and prompt evaluation. An initial screening test for CD includes tissue transglutaminase antibodies. 6 Gliadin antibodies are no longer recommended, although deamidated gliadin antibodies can be helpful in indeterminate cases. Routinely, IgA isotype antibodies are used; all individuals should be screened for IgA deficiency and, if present, should be tested with IgG isotype antibodies. In cases of positive serology or negative serology with high clinical suspicion for CD, the criterion standard diagnostic test, upper endoscopy with multiple bulb and distal duodenum biopsies should be performed. 6 Histologic changes consistent with CD range from inflammation to villous atrophy and are stratified using the Marsh-Oberhuber classification. 6 Once diagnosed, the recommended treatment is a lifelong gluten-free diet after receiving instructions and education from a dietitian with expertise. 6 Generally, patients respond well to this, and if they do not, detailed investigation into inadvertent gluten contamination should be performed before evaluating for alternative diagnoses.
Most cases of CD will have positive serology, but there is a minority in which serology will be negative (5%-10%), termed seronegative CD. This is defined by negative celiac serology, positive histologic findings, and permissive human leukocyte antigen DQ2 and DQ8 haplotypes 7 and is suggested to be the most common cause of villous atrophy in the setting of negative celiac serology. 8 Although the reason for seronegativity is unknown, one hypothesis is that antibodies are trapped in the small intestinal mucosa and do not pass into the bloodstream, in which they could be detected by serological tests. In addition, those who are already limiting gluten in their diets or those who are IgA deficient may inadvertently be grouped into this category. Management of seronegative CD is similar to that of seropositive CD with a strict gluten-free diet. 7 Medications Diarrhea is a common adverse effect of several medications, and certain drugs damage the small intestine itself, resulting in medication-induced enteropathy. Mycophenolate mofetil, azathioprine, methotrexate, and nonsteroidal antiinflammatory drugs are well-recognized culprits. 9 More recently, olmesartan-associated enteropathy has been identified. 10 It is typically classified by severe malabsorptive symptoms commonly leading to nutritional deficiencies and electrolyte abnormalities. 11 Most cases have either human leukocyte antigen DQ2 or DQ8 haplotype. Histologic features, including villous atrophy and a subepithelial collagenous layer consistent with collagenous sprue, can be found in the small bowel, gastric, and colonic mucosa.
11 Diagnosis requires these histologic findings, negative celiac serology, lack of response to a gluten-free diet, and improvement after discontinuing olmesartan. 10 Treatment involves withdrawal of the drug, and in severe cases topical or systemic corticosteroids. Although controversial, some evidence, including a case report on valsartan, suggests that enteropathy may be a class-related drug effect.
11
Collagenous Sprue Collagenous sprue is a rare condition that is part of a family of collagenous gastroenteritides that includes collagenous gastritis and colitis, the latter being the most common. 12 Classically this is a disease of older women, and although the etiology of the collagen deposits is not known, in some cases it is felt to be the pathological consequence of another disease process, such as CD, tropical sprue, or medicationassociated enteropathy. 12, 13 Collagenous sprue is characterized by histologic findings of villous atrophy and a distinct layer of the subepithelial collagen in the small bowel mucosa (usually >20 mm). The presentation can be severe with significant malnutrition. Treatment is targeted at the associated condition (if known) and often also includes topical corticosteroids or immunosuppressants. It is uncommon to have treatment lead to resolution, and previous case reports detail a high risk of mortality, but resolution can potentially be seen in those cases in which the underlying etiology is reversible, such as in the case of comorbid CD or medicationassociated enteropathies.
12,13
Common Variable Immune Deficiency Common variable immune deficiency (CVID) is a rare disorder that can be either congenital or acquired and can therefore occur at any age. This disease involves deficient production of immunoglobulins and is characterized by low levels of at least 2 serum isotypes (other isotypes are IgG, IgE, IgA, IgM, and IgD), frequently IgA.
14 Typically, individuals present with frequent respiratory tract infections and poor response to vaccinations. Diarrhea and malabsorption are common symptoms, and individuals are at risk for intestinal infections (eg, recurrent giardiasis) and small intestinal bacterial overgrowth. In one-third to one-half of cases of CVID, gastrointestinal symptoms are associated with villous atrophy (more commonly partial as opposed to severe), felt to be secondary to dysregulation of the intestinal immune system.
14 Common variable immune deficiency is diagnosed by measuring serum immunoglobulins, and CVID enteropathy is characterized by villous atrophy on histologic examination with little to no plasma cells.
14 Nodular lymphoid hyperplasia is a common finding. Management of the underlying CVID involves intravenous immunoglobulin therapy in certain cases, although this does not help the gastrointestinal involvement and resultant symptoms.
14 Aggressive treatment of associated gastrointestinal tract infections is recommended. Budesonide may be effective for gastrointestinal symptoms after infection has been ruled out. 14 
REVIEW OF ENTEROPATHIES

NOT TO MISS DIAGNOSES OF VILLOUS ATROPHY
Next we shift our discussion to diagnoses that should not be missed.
Human Immunodeficiency Virus
Wasting syndromedmanifested as weight loss, malnutrition, and diarrheadand opportunistic enteric infections are well-known complications of HIV. A lesser known consequence, although common in HIV, is dysfunction of the small intestine in the absence of microorganism infectiondtermed HIV enteropathy. It is debatable whether this enteropathy results from direct damage to the mucosa by the virus or immunological disturbances such as the markedly low level of CD4 þ T cells in the intestinal mucosa. 15 Human immunodeficiency virus enteropathy results in partial villous atrophy, epithelial hypoproliferation, and enterocyte dysfunction leading to decreased brush border enzyme activity causing malabsorption. 15 This entity improves with antiretroviral therapy. It is important to search for HIV as a cause of enteropathy because the infection has devastating consequences and potential for spread if undetected and untreated.
Tropical Sprue
Tropical sprue is an enteropathy that affects travelers to and residents of certain tropical regions. Endemic areas include locations between 30 north and south of the equator, but all nations are not affected equally. 16 It is uncommon in travelers with visits of less than 2 weeks; typically afflicted travelers have stayed for a month or longer. The pathogenesis of tropical sprue is unclear but thought to be infectious (exact pathogen unknown) in nature, with subsequent bacterial overgrowth attacking the structure of the small bowel. 17 The resultant intestinal injury affects absorption, particularly of carbohydrates, fat, vitamin B 12 , and especially folate. It presents with malabsorption, borborygmi, and sequelae of nutritional deficiencies. Intestinal biopsies reveal villous atrophy to a lesser degree than in CD, which supports the diagnosis, but ultimately, response to treatment confirms it. 17 Treatment is with antibiotics (commonly tetracycline) and folate supplementation for a duration of 3 to 6 months. 18 This condition is not to be missed because it can be detected from the history of travel and requires a long course of treatment. In addition, if not managed with behavior change or improved precautions, it can recur, as reexposure to the pathogen is not only possible but likely for those living in the tropics.
Giardiasis
Another infection to be mindful of is Giardia intestinalis (also called giardia lamblia or duodenalis). It is a food-and waterborne parasite with broad geographic reach; it is the leading parasite responsible for enteric infections in the United States. 19 It is frequently found in areas with limited water treatment capacity and poor sanitary conditions. 19 It can also be transmitted fecal-orally. 17 The parasite has 2 forms: cysts and trophozoites. Cysts are infectious and can be ingested and excreted. 19 Trophozoites are pear-shaped multi-flagellated forms and localize to the small intestine in which they attach to the surface but do not invade. 17 Illness is characterized by bloating, flatulence, abdominal cramping, watery diarrhea, malabsorption, and weight loss. Diagnosis is made by stool examination (detection of giardia antigen) or detection of the characteristically shaped organisms by the pathologist. Villous atrophy can be present on small intestinal biopsy. 3 This diagnosis is not to be overlooked, as it is a frequent occurrence in the United States and readily treatable with nitroimidazoles.
Whipple Disease
The gram-positive bacteria Tropheryma whipplei cause this rare multisystem infection. It predominantly affects middle-aged white men. 18 The most common presenting symptom is steatorrhea or diarrhea, resulting in weight loss. This gastrointestinal disturbance is due to impaired lymphatic transport caused by bacteria and can be present years before other areas of the body are attacked. 17 Beyond the small bowel, it can involve essentially any organ system. Its variable systemic presentation can include arthritis, fever, cardiac valve issues, and central nervous system disease such as myoclonus, dementia, oculomasticatory myorhythmia that is pathognomonic of Whipple disease (jaw contractions accompanied by synchronous pendulum-like vergence oscillations in the eyes). 18 It is diagnosed by endoscopy with intestinal biopsy, revealing characteristic periodic acideSchiff stainepositive T whipplei bacteria within macrophages and/or polymerase chain reaction. 18 Slides will also reveal disrupted villous architecture usually affecting the duodenum and jejunum. 17 The optimal treatment is uncertain. The initial phase requires intravenous antibiotics for several weeks (ceftriaxone or penicillin G) followed by a long oral maintenance phase (trimethoprim/sulfamethoxazole or doxycycline plus hydroxychloroquine). 20 This diagnosis is not to be missed, because the prognosis is poor and it can be fatal.
Viral Infection
Perhaps both the most common and overlooked causes of enteropathy are an active viral infection or a post-viral syndrome. Viruses are the main culprit for acute infectious gastroenteritis. Norovirus, rotavirus, adenovirus, and astrovirus are some of the pathogens responsible for outbreaks. 17 Diarrhea can be accompanied by nausea, vomiting, fevers, and abdominal pain. Although the incubation, infectious, and symptomatic (2-8 days) periods are short, with the illness being selflimited, effects to the gastrointestinal system can sometimes be lasting. 17 Viral gastroenteritis can cause abnormal villous shortening, loss of the brush border, compensatory crypt hyperplasia, and lymphocyte infiltration. 17 These changes are temporary and rarely documented because of the short course of illness. Bacterial illnesses such as salmonella, cholera, shigella, typhoid, yersinia, and others also affect the small intestine, but not as often as viral infections. This category is a reminder not to overdiagnose, because viral enteritis is an exceedingly common cause of self-limited diarrhea, which can be elicited through the history and presence of sick contacts.
GENERAL APPROACH TO ENTEROPATHY
When a patient presents with an enteropathy causing clinically significant diarrhea, malabsorption, and weight loss and is found to have villous atrophy, it is reasonable to begin by assessing for CD. Celiac disease is by far the most common cause of villous atrophy (79%-93% of cases) in the United States. 4 If CD is deemed unlikely, we recommend revisiting the history and considering further testing as outlined in Figure 2 . Also examine the biopsy specimen to rule out artifact such as a wholly flattened slide due to operator error during preparation. If just the villi are flat, check the report or ask the pathologist to rereview the slide for clues. Special stains can also be requested. Many diseases seen by staining are rare or suggested by the history; these studies should be reserved for the appropriate clinical scenario. The biopsy of tropical sprue and medication-associated enteropathy mimic CD. Working in a stepwise fashion by evaluating for CD and if negative, performing tests on serum and biopsy, as guided by clinical suspicion, is our suggested approach to working up an enteropathy.
TREATMENT
After an etiology is uncovered, treatment is dictated by the underlying cause. Corticosteroids are frequently useful, as they help subdue inflammation. Guidelines are often practical sources for current clinical information. 6 The Table references treatment options.
CONCLUSION
Enteropathies encompass a wide spectrum of illness; they cause diarrhea, nutritional deficiencies, and weight loss. A detailed and careful approach can often reveal the underlying cause.
An example of such a work-up is described in this article, featuring the most common and not to miss enteropathies. We hope that it is of particular use in scenarios in which CD is not the final diagnosis and so it may broaden the differential diagnosis and awareness of other illnesses, because not all that flattens is CD. 
